loader
Please Wait
Applying Filters...

Quotient Sciences Quotient Sciences

X
menu

    Market Place

    Market Place

    Post Enquiry

    Post Enquiry
    menu

    Approved Drug Products containing 201657 listed in the FDA Orange Book. Original Data : FDA Website

    Client Virtual Booth
    Menu

    Hospira, Inc.

    EVENTS

    • Webinars & Exhibitions

    PRESENTATION(s)

    VIDEO(s)

    DIGITAL CONTENT

    APIs // Active Pharmaceutical Ingredients

    DEVELOPMENTS

    DOSSIERs // Finished Dosage Forms

    INSPECTIONS & REGISTRATIONS

    PharmaCompass

    LGM Pharma accelerates & optimizes the new product pathway from early development through commercialization.

    Send me more info on How To Grow My Business Digitally?

    Left Arrow
    Right Arrow
    Filters Filter
    Cross PopUp
    FILTER :

    filter

    01 HOSPIRA (3)

    filter

    01 SOLUTION;INTRAVENOUS (3)

    filter

    01 RX (3)

    filter

    01 PARICALCITOL (3)

    filter

    01 No (3)

    ListList of Suppliers
    refresh Reset Filter
    refresh Reset Filter
    product-page Supplier Virtual Booth
    price-trend Ask Us
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    PARICALCITOL

    PDF Supplier PDF
    URL Supplier Web Content
    SOLUTION; INTRAVEN...
    0.002MG/ML (0.002M...
    2014-10-21
    201657
    PARICALCITOL
    RX
    No
    AP
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    PARICALCITOL

    PDF Supplier PDF
    URL Supplier Web Content
    SOLUTION; INTRAVEN...
    0.005MG/ML (0.005M...
    2014-10-21
    201657
    PARICALCITOL
    RX
    No
    AP
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content
    Contact Supplier
    • FDA
    • EDQM
    • WHO-GMP
    Virtual Booth Upload your Marketing & Sales content on your company Virtual Booth, click HERE
    Post an Enquiry Post an Enquiry
    Flag U.S.A
    Virtual Booth Virtual Booth
    Digital Content Digital Content

    PARICALCITOL

    PDF Supplier PDF
    URL Supplier Web Content
    SOLUTION; INTRAVEN...
    0.01MG/2ML (0.005M...
    2014-10-21
    201657
    PARICALCITOL
    RX
    No
    AP
    ASK
    US
    PHARMACOMPASS
    Upload
    your Marketing & Sales content

    Looking for FDA Orange Book APPLICATION 201657

    Looking for FDA Orange Book APPLICATION 201657 3

    19

    Hospira, Inc., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is PARICALCITOL, with a corresponding application number 201657.

    Regulatory Information RX

    With a dosage strength 0.002MG/ML (0.002MG/ML)

    Dosage Form Route SOLUTION; INTRAVENOUS

    Reference Listed Drug No

    Approved since 2014-10-21

    Therapeutic Equivalence (TE) Code AP

    18

    Hospira, Inc., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is PARICALCITOL, with a corresponding application number 201657.

    Regulatory Information RX

    With a dosage strength 0.005MG/ML (0.005MG/ML)

    Dosage Form Route SOLUTION; INTRAVENOUS

    Reference Listed Drug No

    Approved since 2014-10-21

    Therapeutic Equivalence (TE) Code AP

    17

    Hospira, Inc., based in U.S.A, is a pharmaceutical company that stands out with its certifications from FDA, EDQM and WHO-GMP.

    One of their notable products is PARICALCITOL, with a corresponding application number 201657.

    Regulatory Information RX

    With a dosage strength 0.01MG/2ML (0.005MG/ML)

    Dosage Form Route SOLUTION; INTRAVENOUS

    Reference Listed Drug No

    Approved since 2014-10-21

    Therapeutic Equivalence (TE) Code AP

    Post Enquiry
    POST ENQUIRY